tiprankstipranks
Advertisement
Advertisement

TSE:ADK Stock Latest News

Company AnnouncementsDiagnos Advances Global Regulatory Push for Next‑Generation CARA Eye‑Disease Platform
5d ago
PremiumCompany Announcements
Diagnos Renews U.S. FDA Registration and Extends Warrant Expiry
12d ago
PremiumCompany Announcements
Diagnos to Showcase AI Eye-Health Platform at Toronto Growth Investor Conference
2M ago
PremiumCompany Announcements
Diagnos Wins $1M-Plus Federal Backing for Next-Generation Retinal AI Research
2M ago
Diagnos Hires Investor Brand Network to Boost Market Visibility
PremiumCompany Announcements
Diagnos Hires Investor Brand Network to Boost Market Visibility
3M ago
Diagnos Advances Global Regulatory Push for AI Eye-Health Platform CARA
PremiumCompany AnnouncementsDiagnos Advances Global Regulatory Push for AI Eye-Health Platform CARA
3M ago
DIAGNOS Appoints New Chief AI Scientist to Propel Healthcare Innovation
Premium
Company Announcements
DIAGNOS Appoints New Chief AI Scientist to Propel Healthcare Innovation
4M ago
Diagnos Inc. Closes $4 Million Oversubscribed Private Placement
Premium
Company Announcements
Diagnos Inc. Closes $4 Million Oversubscribed Private Placement
4M ago
Diagnos Inc. Upsizes Private Placement to $3.65M Amid Strong Demand
PremiumCompany Announcements
Diagnos Inc. Upsizes Private Placement to $3.65M Amid Strong Demand
5M ago
Diagnos Inc. Extends Stock Warrant Exercise Period
PremiumCompany Announcements
Diagnos Inc. Extends Stock Warrant Exercise Period
5M ago
Diagnos Inc. Launches $2 Million Private Placement to Support Growth
PremiumCompany Announcements
Diagnos Inc. Launches $2 Million Private Placement to Support Growth
5M ago
DIAGNOS Appoints Philippe Couillard as Chairman Amid Expansion Efforts
PremiumCompany Announcements
DIAGNOS Appoints Philippe Couillard as Chairman Amid Expansion Efforts
5M ago
DIAGNOS Strengthens Advisory Board with New Appointment
PremiumCompany AnnouncementsDIAGNOS Strengthens Advisory Board with New Appointment
6M ago
Diagnos Inc. Extends Stock Warrant Exercise Period
Premium
Company Announcements
Diagnos Inc. Extends Stock Warrant Exercise Period
6M ago
DIAGNOS to Showcase Growth Potential at Bahamas Summit
Premium
Company Announcements
DIAGNOS to Showcase Growth Potential at Bahamas Summit
6M ago
DIAGNOS Achieves MDSAP Audit Success, Paving Way for Global Expansion
PremiumCompany Announcements
DIAGNOS Achieves MDSAP Audit Success, Paving Way for Global Expansion
6M ago
DIAGNOS Inc. Announces Shareholder Meeting Results and Stock Option Grants
PremiumCompany Announcements
DIAGNOS Inc. Announces Shareholder Meeting Results and Stock Option Grants
7M ago
Diagnos Inc. Closes $100,000 Private Placement for AI Development
PremiumCompany Announcements
Diagnos Inc. Closes $100,000 Private Placement for AI Development
7M ago
DIAGNOS Inc. Announces $100,000 Private Placement for AI Product Development
PremiumCompany Announcements
DIAGNOS Inc. Announces $100,000 Private Placement for AI Product Development
7M ago
Diagnos Inc. Extends Stock Warrants Exercise Period and Corrects Previous Announcement
PremiumCompany AnnouncementsDiagnos Inc. Extends Stock Warrants Exercise Period and Corrects Previous Announcement
8M ago
Diagnos Inc. Extends Stock Warrants Exercise Period
Premium
Company Announcements
Diagnos Inc. Extends Stock Warrants Exercise Period
8M ago
DIAGNOS Advances into U.S. Optometry Market with FDA Pre-Submission for CARA System
Premium
Company Announcements
DIAGNOS Advances into U.S. Optometry Market with FDA Pre-Submission for CARA System
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >